{"id":"https://openalex.org/W2017402153","doi":"https://doi.org/10.3851/imp1397","title":"Elvitegravir: A New HIV Integrase Inhibitor","display_name":"Elvitegravir: A New HIV Integrase Inhibitor","alternate_titles":[],"publication_year":2009,"publication_date":"2009-10-01","ids":{"openalex":"https://openalex.org/W2017402153","doi":"https://doi.org/10.3851/imp1397","mag":"2017402153","pmid":"https://pubmed.ncbi.nlm.nih.gov/19843978"},"language":"en","primary_location":{"id":"doi:10.3851/imp1397","doi":"https://doi.org/10.3851/imp1397","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp1397","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP1397","source":{"id":"https://openalex.org/S201936961","display_name":"Antiviral chemistry & chemotherapy","issn_l":"0956-3202","issn":["0956-3202","2040-2066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Chemistry and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017402153"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP1397","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026805844","display_name":"Kazuya Shimura","orcid":"https://orcid.org/0000-0001-7819-5184","observed_orcids":["https://orcid.org/0000-0001-7819-5184"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kazuya Shimura","raw_affiliation_strings":["Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan","institution_ids":["https://openalex.org/I22299242"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014781635","display_name":"Eiichi N. Kodama","orcid":"https://orcid.org/0000-0002-6622-2752","observed_orcids":["https://orcid.org/0000-0002-6622-2752"]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]},{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Eiichi N Kodama","raw_affiliation_strings":["Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan","Present address: Division of Emerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Japan","#N# 1 Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan","#N# 2 Present address: Division of Emerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan","institution_ids":["https://openalex.org/I22299242"]},{"raw_affiliation_string":"Present address: Division of Emerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Japan","institution_ids":["https://openalex.org/I201537933"]},{"raw_affiliation_string":"#N# 1 Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan","institution_ids":["https://openalex.org/I22299242"]},{"raw_affiliation_string":"#N# 2 Present address: Division of Emerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Japan","institution_ids":["https://openalex.org/I201537933"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5014781635"],"corresponding_institution_ids":["https://openalex.org/I201537933","https://openalex.org/I22299242"],"apc_list":{"value":1500,"currency":"USD","value_usd":1500},"apc_paid":null,"fwci":0.9628,"has_fulltext":true,"cited_by_count":107,"citation_normalized_percentile":{"value":0.65406275,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"20","issue":"2","first_page":"79","last_page":"85"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/elvitegravir","display_name":"elvitegravir","score":1.0},{"id":"https://openalex.org/keywords/hiv-integrase-inhibitors","display_name":"HIV integrase inhibitors","score":0.8489999771118164},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.7400000095367432},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.8870000243186951},{"id":"https://openalex.org/keywords/antiviral-drug-discovery","display_name":"antiviral drug discovery","score":0.515999972820282},{"id":"https://openalex.org/keywords/integrase-resistance-mutations","display_name":"integrase resistance mutations","score":0.8479999899864197},{"id":"https://openalex.org/keywords/retroviral-replication","display_name":"retroviral replication","score":0.47999998927116394},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.8539999723434448}],"concepts":[{"id":"https://openalex.org/C2777068322","wikidata":"https://www.wikidata.org/wiki/Q2740966","display_name":"Elvitegravir","level":5,"score":0.9960806369781494},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.9698166847229004},{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.9078100919723511},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.8748508095741272},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6444302797317505},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5634025931358337},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4176861643791199},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2601243257522583},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2044735848903656},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.10716834664344788}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012190","descriptor_name":"Retroviridae","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3851/imp1397","doi":"https://doi.org/10.3851/imp1397","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp1397","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP1397","source":{"id":"https://openalex.org/S201936961","display_name":"Antiviral chemistry & chemotherapy","issn_l":"0956-3202","issn":["0956-3202","2040-2066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Chemistry and Chemotherapy","raw_type":"journal-article"},{"id":"pmid:19843978","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19843978","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral chemistry & chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3851/imp1397","doi":"https://doi.org/10.3851/imp1397","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp1397","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP1397","source":{"id":"https://openalex.org/S201936961","display_name":"Antiviral chemistry & chemotherapy","issn_l":"0956-3202","issn":["0956-3202","2040-2066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Chemistry and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309773","display_name":"Japan Health Sciences Foundation","ror":"https://ror.org/04z7xfj55"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017402153.pdf","grobid_xml":"https://content.openalex.org/works/W2017402153.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W86894734","https://openalex.org/W170094209","https://openalex.org/W192927429","https://openalex.org/W1480425134","https://openalex.org/W1496518737","https://openalex.org/W1576999979","https://openalex.org/W1846959000","https://openalex.org/W1983837630","https://openalex.org/W1989276338","https://openalex.org/W1992276570","https://openalex.org/W2007831756","https://openalex.org/W2007996101","https://openalex.org/W2012297504","https://openalex.org/W2025444624","https://openalex.org/W2029289386","https://openalex.org/W2030854058","https://openalex.org/W2033276174","https://openalex.org/W2041921162","https://openalex.org/W2054595210","https://openalex.org/W2054996337","https://openalex.org/W2068095506","https://openalex.org/W2072867223","https://openalex.org/W2085468466","https://openalex.org/W2089882643","https://openalex.org/W2102696289","https://openalex.org/W2104029568","https://openalex.org/W2139266935","https://openalex.org/W2139876724","https://openalex.org/W2145727571","https://openalex.org/W2150504993","https://openalex.org/W2150655989","https://openalex.org/W2151389386","https://openalex.org/W2154190260","https://openalex.org/W2167278859","https://openalex.org/W2318289184"],"related_works":["https://openalex.org/W2150306873","https://openalex.org/W1982056517","https://openalex.org/W2133594819","https://openalex.org/W2154498922","https://openalex.org/W2157913001","https://openalex.org/W1790877993","https://openalex.org/W302056891","https://openalex.org/W2060696966","https://openalex.org/W2064131094","https://openalex.org/W2037625569"],"abstract_inverted_index":{"Integration":[0],"is":[1,77],"a":[2,91],"distinctive":[3],"and":[4,12,57,123,129,132,138],"essential":[5],"process":[6],"in":[7,81,99,121,124],"the":[8,42,68,105,133],"HIV":[9,34,128],"infection":[10],"cycle":[11],"thus":[13],"represents":[14],"an":[15],"attractive":[16],"antiviral":[17,93],"drug":[18,27],"target.":[19],"Integrase":[20],"inhibitors":[21],"combined":[22],"with":[23,114],"other":[24,130],"classes":[25],"of":[26,33,70,88,97,108,119,135],"might":[28],"contribute":[29],"to":[30,95],"long-lasting":[31],"suppression":[32],"type-1":[35],"(HIV-1)":[36],"replication":[37],"for":[38,67],"many":[39],"patients.":[40,72,101],"Of":[41],"numerous":[43],"potential":[44],"integrase":[45,74,116,136],"inhibitor":[46],"leads":[47],"that":[48],"have":[49,53],"been":[50,62],"reported,":[51],"few":[52],"reached":[54],"clinical":[55,84],"trials":[56],"only":[58],"one,":[59],"raltegravir,":[60],"has":[61,90],"approved":[63],"(in":[64],"late":[65],"2007)":[66],"treatment":[69],"HIV-1-infected":[71,100],"Another":[73],"inhibitor,":[75],"elvitegravir,":[76],"currently":[78],"showing":[79],"promise":[80],"Phase":[82],"III":[83],"studies.":[85],"Once-daily":[86],"administration":[87],"elvitegravir":[89],"comparable":[92],"activity":[94,126],"twice-daily":[96],"raltegravir":[98],"Here,":[102],"we":[103],"highlight":[104],"salient":[106],"features":[107],"elvitegravir:":[109],"its":[110,142],"chemical":[111],"structure":[112],"compared":[113],"representative":[115],"inhibitors,":[117],"mechanism":[118],"action,":[120],"vitro":[122],"vivo":[125],"against":[127],"retroviruses,":[131],"effect":[134],"polymorphisms":[137],"resistance":[139],"mutations":[140],"on":[141],"anti-HIV":[143],"activity.":[144]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017402153","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
